Editorial Feature

Nanomaterial-Based Biosensors and Early Disease Detection

Advanced biosensors have become a key priority for researchers within the field of biomedicine and nanotechnology to detect biomarkers associated with an array of diseases and disorders. This may be revolutionary as early disease detection can prevent morbidity and mortality rates, especially at a younger age, which may be helpful in patients with diabetes, cancer, and neurological disorders such as Alzheimer's disease.

Nanomaterial-Based Biosensors and Early Disease Detection

Image Credit: kittirat roekburi/Shutterstock.com

Background

There has been an increase in the volume of patients with diseases such as diabetes, cancer, and Alzheimer's disease, as well as the associated mortality rates relating to these.

The use of nanotechnology-based biosensors for early disease detection may advance research into preventing disease progression through the identification of associated biomarkers.

Diabetes mellitus can lead to an increased level of glucose in the blood, which can cause adverse effects such as heart disease, kidney failure and blindness. The detection of glucose concentration as a biomarker can greatly impact the progression of diabetes in patients, aiding with effective disease management.

Similarly, other types of diseases, including cancer and neurodegenerative diseases such as Alzheimer's, can also be detected through biomarkers to assist with early diagnosis; this may be more useful than current disease approaches, which are ineffective due to a lack of suitable treatment.

The World Health Organization has stated cancer as the main causative agent responsible for 10 million deaths globally in 2020, while Alzheimer's statistic reports have revealed 121,499 associated deaths in 2019.

Nanomaterial-Based Biosensors

According to the European commission's recommendation in 2011, nanomaterials can be described as "a natural, incidental or manufactured material containing particles, in an unbound state or as an aggregate or as an agglomerate and where, for 50% or more of the particles in the number size distribution, one or more external dimensions is in the size range 1 nm–100 nm".

These materials can be categorized into four key groups, including (i) carbon-based nanomaterials, such as graphene or carbon nanotubes, (ii) inorganic-based nanomaterials such as metal oxide nanoparticles, (iii) organic-based nanomaterials including liposomes, and (iv) composite-based nanomaterials including hybrid nanofibers.

Nanomaterials have remarkable physiochemical properties, as well as good electrical and optical features that allow them to be beneficial for biosensor applications.

Biosensors can be described as analytical devices based on receptors and transducers, with the former aiding detection and the latter assisting in response measurements. These devices can be used for recognizing biomarkers, including but not limited to enzymes, proteins, and antibodies.

Carbon-Based Nanomaterial Biosensors

Carbon-based nanomaterials such as one-dimensional carbon nanotubes and two-dimensional graphene have been an attractive point of research within biosensor development.

Interestingly, these electrochemical sensors can convert biological reactions, including enzyme-substrate reactions, into electrical signals. Using nanomaterials within biosensors involves surface functionalization, which can be beneficial for the precise targetability of analytes. This can also enhance the biorecognition component of these advanced biosensors, subsequently impacting other properties such as specificity and sensitivity.

Other key benefits of utilizing nanomaterial-based biosensors include the ability to reuse the device, which can influence the overall expenditure of biosensors, benefitting the commercial market for both the creators and consumers of the products.

Carbon-based nanomaterials are strong candidates for biosensor development due to their ability to function in harsh conditions while maintaining a high level of sensitivity and specificity within various temperatures. This can be applied in detecting biomarkers, including glucose concentration and protein markers for diseases, due to withstanding the human body conditions in vivo.

Graphene-Based Biosensors

Graphene, a significant allotrope of carbon, has also gained traction in nanomaterial research due to critical features that have advanced applications in fields from medicine to electronics. However, limitations such as lack of quantity and its hydrophobic nature have withheld this unique nanomaterial's potential for biosensor applications.

Interestingly, these challenges have been addressed by researchers that used graphene oxide to increase the hydrophilicity of the material and improve the electrical conductivity properties. This has enabled graphene oxide to be utilized for optical biosensors, such as for photoluminescence and label-free optical biosensor development.

Gold Nanomaterial-Based Biosensors

Gold is an interesting element in nanotechnology due to its remarkable properties at the nanoscale, including higher reactivity.

Gold nanomaterials have been used in electrochemical sensor research due to benefits such as good electrical conductivity as well as a large surface ratio.

Gold nanomaterials for this application can also enable surface functionalization for higher targetability of analytes, as well as incorporation with other composites and elements; this can include poly(diallyldimethylammonium chloride)-functionalized graphene oxide and chitosan to enhance the critical biosensor properties such as specificity, sensitivity and stability of the device.

Future Outlook

The development of optical and electrochemical biosensors with nanomaterials can advance these analytical devices, enhancing properties such as the sensitivity and specificity of analytes. These devices can also innovate the detection of biomarkers for early disease detection with the potential of developing rapid point-of-care devices that would be revolutionary for diagnostics.

Additionally, with electrodes that can be used as microchips, the potential for creating products with a higher level of sustainability may also be advantageous for both the medical and electronic fields.

However, current challenges facing researchers include the miniaturization of the devices, as well as integrating them with fluid systems and multichip systems. Further research into these areas can provide potential solutions for the detection of novel viruses, such as the SARS-CoV-2 virus, responsible for the COVID-19 pandemic, as well as many other infectious diseases from diabetes to neurodegenerative diseases that impact world health.

Continue reading: Nanotechnology in Point-of-Care Testing

Further Reading and References

Alzheimer's & Dementia, (2021) Alzheimer's disease facts and figures. 17(3), pp.327-406. Available at: https://doi.org/10.1002/alz.12328

Fahmy, H., Abu Serea, E., Salah-Eldin, R., Al-Hafiry, S., Ali, M., Shalan, A. and Lanceros-Méndez, S., (2022) Recent Progress in Graphene- and Related Carbon-Nanomaterial-based Electrochemical Biosensors for Early Disease Detection. ACS Biomaterials Science & Engineering, 8(3), pp.964-1000. Available at: https://doi.org/10.1021/acsbiomaterials.1c00710

Sheikhzadeh, E., Beni, V. and Zourob, M., (2021) Nanomaterial application in bio/sensors for the detection of infectious diseases. Talanta, 230, p.122026. Available at: 10.1016/j.talanta.2020.122026

Who.int. (2022) Cancer. [online] Available at: https://www.who.int/news-room/fact-sheets/detail/cancer

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Marzia Khan

Written by

Marzia Khan

Marzia Khan is a lover of scientific research and innovation. She immerses herself in literature and novel therapeutics which she does through her position on the Royal Free Ethical Review Board. Marzia has a MSc in Nanotechnology and Regenerative Medicine as well as a BSc in Biomedical Sciences. She is currently working in the NHS and is engaging in a scientific innovation program.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Khan, Marzia. (2022, June 14). Nanomaterial-Based Biosensors and Early Disease Detection. AZoNano. Retrieved on June 14, 2024 from https://www.azonano.com/article.aspx?ArticleID=6166.

  • MLA

    Khan, Marzia. "Nanomaterial-Based Biosensors and Early Disease Detection". AZoNano. 14 June 2024. <https://www.azonano.com/article.aspx?ArticleID=6166>.

  • Chicago

    Khan, Marzia. "Nanomaterial-Based Biosensors and Early Disease Detection". AZoNano. https://www.azonano.com/article.aspx?ArticleID=6166. (accessed June 14, 2024).

  • Harvard

    Khan, Marzia. 2022. Nanomaterial-Based Biosensors and Early Disease Detection. AZoNano, viewed 14 June 2024, https://www.azonano.com/article.aspx?ArticleID=6166.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.